FTHFX | NSMVX | FTHFX / NSMVX | |
Total Expense Ratio | 0.63 | 1.39 | 45% |
Annual Report Gross Expense Ratio | 0.63 | 1.39 | 45% |
Fund Existence | 14 years | 12 years | - |
Gain YTD | -11.184 | -15.188 | 74% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 5000 | 20,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.26B | 98.9M | 9,367% |
Annual Yield % from dividends | 0.82 | 0.80 | 102% |
Returns for 1 year | -8.97 | -7.74 | 116% |
Returns for 3 years | 21.34 | 0.43 | 4,993% |
Returns for 5 years | 97.43 | 78.32 | 124% |
Returns for 10 years | 76.65 | 30.47 | 252% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CNCR | 10.16 | 0.29 | +2.94% |
Range Cancer Therapeutics ETF | |||
GOEX | 41.35 | 0.93 | +2.31% |
Global X Gold Explorers ETF | |||
DWM | 59.77 | 0.62 | +1.05% |
WisdomTree International Equity ETF | |||
EXG | 7.86 | 0.07 | +0.90% |
Eaton Vance Tax-Managed Global Diversified Equity Income Fund | |||
THD | 52.81 | 0.13 | +0.25% |
iShares MSCI Thailand ETF |